Provider Bulletin: [Subject]
Desmopressin acetate (DDAVP) -- DDAVP is considered the treatment of choice for mild and moderate hemophilia A. It is not effective in the treatment of severe hemophilia. It stimulates a transient increase in plasma FVIII levels and results in sufficient hemostasis to stop a bleeding episode or to prepare patients for dental and minor surgical ... ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- ec doe education bulletin 2019
- heritage provider network provider portal
- ecdoe bulletin 2019
- louisiana believes bulletin 137
- bulletin 137 louisiana child care law
- bulletin board supplies
- louisiana licensing regulation bulletin 137
- post bulletin online newspaper
- louisiana believes bulletin 137 revised
- acog practice bulletin 175
- acog practice bulletin 174
- acog practice bulletin 128